Cardiac Biomarkers in Heart Failure

James Aguanno, PhD 

Enlarged Heart Image

Join us for a comprehensive review of heart failure (HF), the pathophysiological state in which the heart fails to pump enough blood to meet the demands of the body. The discussion reviews the American College of Cardiology Foundation (ACCF) and American Heart Association (AHA) Heart Failure Guidelines for ambulatory outpatients with suspected heart failure and hospitalized acute patients. The wide array of test procedures used in the diagnosis of heart failure are examined, with particular attention to the natriuretic peptides NT-proBNP and BNP.

  • Understand the definition of heart failure, the underlying causes, and the signs and symptoms.
  • Review the current heart failure guidelines for both acute and ambulatory patients.
  • Recognize the clinical performance of both NT-proBNP and BNP assay in patients with heart failure.
  • Review the multiple options available for the treatment of patients with heart failure.

P.A.C.E. and ACCENT credits are available to registrants who participate.

  • Emergency room (A&E) physicians, nurses and ER technicians
  • Point-of-care coordinators
  • Laboratory personnel
  • Cardiac physicians
James Aguanno, PhD 

Dr. Aguanno received a PhD in biochemistry from Memphis State University. Following his PhD, he completed two postdoctoral fellowships: one at the University of Pittsburgh School of Medicine, and a second at Washington University School of Medicine and Barnes Hospital in St. Louis, Missouri. Dr. Aguanno was Director of the Core Laboratory at Baylor University Medical Center in Dallas, Texas, for 24 years. In January 2004, he joined Siemens Healthcare Diagnostics and is currently Senior Clinical Specialist in the Disease State Management group.